Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA562452
Title Engineered PlyCB as a Novel Implant Coating for Osseointegration.
Publication Date Mar 2012
Media Count 15p
Personal Author D. Nelson
Abstract Orthopedic implant materials are often not compatible with osteoblasts, bone cells responsible for formation of new bone. The lack of osseointegration is the primary cause of implant failure or shortened lifespan under physiological loads. Coatings such as hydroxyapatite, the mineral component of bone, are often used to promote integration of bone with implant. However, hydroxyapatite coatings do not contain any inherent bioactive properties. Integrins are a family of bioactive proteins that promote adherence of osteoblasts to extracellular matrix proteins. Significantly, the tri-peptide sequence Arg-Gly-Asp, or RGD , is sufficient to direct binding to several of the predominant integrins including 3, which is displayed by osteoblasts (Morra, 2006). Engineering orthopedic surfaces to display proteins or short peptides such as RGD is an ongoing challenge to the biomaterial field (Carson, 2007; Tsiridis, 2007; Axelrad, 2007; Schuler, 2006). Interestingly, PlyCB, a bacteriophage-derived protein, was found to have a particularly high affinity for hydroxyapatite (Nelson, 2006). Based on the crystal structure, we plan to introduce mutants to PlyCB that will display the RGD motif and hopefully retain the natural ability of this protein to bind hydroxyapatite. The biochemical and biophysical properties of PlyCB when bound to hydroxyapatite will be investigated by several methods. Finally, a sandwich of titanium implant, hydroxyapaptite coating, and PlyCB-RGD mutants will be made and binding to cultured osteoblasts will be determined by fluorescent binding assays. Future proposals will be aimed at in vivo implant models to show increased osteoblast formation on PlyCB-RGD treated implants. Additionally, we envision the ability to display other bonestimulating factors on the surface of PlyCB in future proposals.
Keywords Bioactive coating
Surgical implantation
Titanium implant

Source Agency Non Paid ADAS
NTIS Subject Category 57A - Anatomy
57S - Physiology
57E - Clinical Medicine
95A - Prosthetics & Mechanical Organs
Corporate Author Maryland Univ., College Park.
Document Type Technical report
Title Note Final rept. 1 Sep 2010-29 Feb 2012.
NTIS Issue Number 1225
Contract Number W81XWH-10-1-0572

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader